AmgenvsSotera Health

AMGN and SHC stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$443.89

Value $239B

-0.95%
AMGN's page

SHC

Sotera Health Company

$16.28

Value $4.6B

-1.23%
SHC's page

Amgen (AMGN) has a market value of $239B and Sotera Health (SHC) $4.6B. Over the last year, with dividends, AMGN moved +39.7% and SHC +2.6%. The P/E is 25.5 for AMGN and 26.7 for SHC. Dividend yield: AMGN 2.24%, SHC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$239B

    SHC$4.6B

    AMGN is 52 times SHC

  • Revenue, 12 months

    AMGN$38.9B

    SHC$1.2B

    AMGN is 32 times SHC

  • Net income, 12 months

    AMGN$9.4B

    SHC$173M

    AMGN is 54 times SHC

  • Operating margin

    AMGN32.4%

    SHC–

  • ROIC

    AMGN16.2%

    SHC6.3%

    9.9 points apart

  • P/E

    AMGN25.5

    SHC26.7

    About the same

  • Dividend yield

    AMGN2.2%

    SHC0.0%

    2.2 points apart

  • 5-year return

    AMGN+158.3%

    SHC-32.2%

    190.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+158.3%

SHC-32.2%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsSHCWith dividends
1 year since November 14, 2025+39.7%Price +36.0%+2.6%Price +2.6%
3 years since November 17, 2023+87.3%+23.3% a yearPrice +72.5%+17.6%+5.5% a yearPrice +17.6%
5 years since November 16, 2021+158.3%+20.9% a yearPrice +123.0%-32.2%-7.5% a yearPrice -32.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenSHCSotera Health

Valuation

AMGNSHC
Valuation
Price$443.89$16.28
Market value$239B$4.6B
Enterprise value (EV)$280B$6.5B
P/E25.526.7
P/E, 5-year median23.075.4
P/B16.76.3
EV/EBIT22.223.5
Free cash flow yield4.0%2.9%

Results and growth

AMGNSHC
Results and growth
Revenue, 12 months$38.9B$1.2B
Net income, 12 months$9.4B$173M
Free cash flow, 12 months$9.6B$135M
Earnings per share, 12 months$17.25$0.60
Revenue growth, year on year10.0%5.7%
Revenue growth a year, past+7.6%over 5 years+7.3%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNSHC
Margins and returns on capital
Gross margin70.9%54.6%
Operating margin32.4%–
Net margin24.1%14.1%
ROIC16.2%6.3%
ROE87.8%27.3%

Balance sheet

AMGNSHC
Balance sheet
Cash$13.2B$412M
Total debt$54.0B$2.3B
Net debt / EBITDA2.35.0
Interest cover4.8×–

Dividends and buybacks

AMGNSHC
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or SHC

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Sotera Health?

By market value, Amgen ($239B) is about 51.7 times Sotera Health ($4.6B), at today's prices.

How did AMGN and SHC stock do over the last 5 years?

Since November 16, 2021, AMGN's price moved +123.0% and SHC's -32.2%. With dividends: AMGN +158.3% (+20.9% a year), SHC -32.2% (-7.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or SHC?

The dividend yield at today's price is 2.24% for Amgen and none for Sotera Health. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and SHC?

At today's price, the P/E is 25.5 for AMGN and 26.7 for SHC. The median of the last five years was 23.0 and 75.4, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Sotera Health?

Over the last twelve months, the net margin was 24.1% for Amgen and 14.1% for Sotera Health, and the operating margin 32.4% and –. Revenue was $38.9B and $1.2B.

Which is the better investment, Amgen or Sotera Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.